Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€36.70

€36.70

-0.810%
-0.3
-0.810%
-
 
09.05.24 / Frankfurt WKN: 870481 / Name: Guerbet / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Guerbet

sharewise wants to provide you with the best news and tools for Guerbet, so we directly link to the best financial data sources.

News

Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: 2023 full-year results.
Guerbet: 2023 full-year results.
Guerbet: 2023 full-year results.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.
Guerbet: 2023 revenue
Guerbet: 2023 revenue
Guerbet: 2023 revenue
Guerbet: Death of Michel Guerbet, son of the founder and company director for over 30 years.
Guerbet: Death of Michel Guerbet, son of the founder and company director for over 30 years.
Guerbet: Death of Michel Guerbet, son of the founder and company director for over 30 years.